RPCA
CEMI

Running Point Capital Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Running Point Capital Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$2.2K – 215
2022
Q4 		$2.2K Hold
10,000
– – ﹤0.01% 203
2022
Q3 		$4K Hold
10,000
– – ﹤0.01% 211
2022
Q2 		$7K Hold
10,000
– – ﹤0.01% 209
2022
Q1 		$8K Buy
+10,000
New +$9.33K ﹤0.01% 205

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Running Point Capital Advisors's CEMI Position: Q1 2023 in Review

Running Point Capital Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 10,000 shares — an estimated $2.2K sold.

Running Point Capital Advisors first reported a position in CEMI in Q1 2022 and held it in 4 quarters. The position peaked at $8K in Q1 2022. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

  • Running Point Capital Advisors reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Running Point Capital Advisors sold 10,000 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $2.2K.
  • Running Point Capital Advisors first reported a position in Chembio diagnostics, Inc. in Q1 2022 and held it in 4 quarters.
  • Running Point Capital Advisors's Chembio diagnostics, Inc. position peaked at $8K in Q1 2022.
  • 30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Running Point Capital Advisors's 13F filing for Q1 2023, filed 10 May 2023.